Literature DB >> 10738250

Radiation-induced expression of functional Fas ligand in EBV-positive human nasopharyngeal carcinoma cells.

B Abdulkarim1, S Sabri, E Deutsch, S Vaganay, E Marangoni, W Vainchenker, P Bongrand, P Busson, J Bourhis.   

Abstract

Ionizing radiation remains a major therapeutic tool against human cancers, especially epithelial tumors, which account for the majority of human malignancies. Although Fas and Fas-L are essential determinants of apoptosis, few data support their role in the cytotoxic effect of ionizing radiation. Epstein-Barr-virus (EBV)-positive nasopharyngeal carcinoma (NPC) were chosen to address this question owing to their known sensitivity to ionizing radiation and their constitutive expression of the Fas-receptor. We here report that, in xenografted NPC cells, Fas-L expression, which was very low in basal conditions, was dramatically increased by tumor irradiation. Both the Fas receptor and the Fas ligand were found to be functional in this model, and a high proportion of irradiated NPC cells underwent apoptosis following tumor irradiation. Induction of Fas-L expression and apoptosis were observed for doses as low as 2 Gy. These data show an increase in Fas-L expression upon irradiation exposure, and strongly suggest that, in some epithelial malignancies, Fas-mediated apoptosis can play a major role in the anti-tumor effect of ionizing radiation, in the range of doses used for therapeutic applications. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10738250     DOI: 10.1002/(sici)1097-0215(20000415)86:2<229::aid-ijc12>3.0.co;2-1

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

Review 1.  Immunomodulatory effects of radiation: what is next for cancer therapy?

Authors:  Anita Kumari; Samantha S Simon; Tomika D Moody; Charlie Garnett-Benson
Journal:  Future Oncol       Date:  2015-12-01       Impact factor: 3.404

2.  Radiation-induced tumor neoantigens: imaging and therapeutic implications.

Authors:  Christopher D Corso; Arif N Ali; Roberto Diaz
Journal:  Am J Cancer Res       Date:  2011-01-25       Impact factor: 6.166

Review 3.  Epstein-Barr virus infection and human malignancies.

Authors:  G Niedobitek; N Meru; H J Delecluse
Journal:  Int J Exp Pathol       Date:  2001-06       Impact factor: 1.925

Review 4.  Role of Mitochondria in Radiation Responses: Epigenetic, Metabolic, and Signaling Impacts.

Authors:  Dietrich Averbeck; Claire Rodriguez-Lafrasse
Journal:  Int J Mol Sci       Date:  2021-10-13       Impact factor: 5.923

5.  X-ray induced L02 cells damage rescued by new anti-oxidant NADH.

Authors:  Fa-Quan Liu; Ji-Ren Zhang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

6.  Induction of Fas (CD95/APO-1) ligand is essential for p53-dependent apoptosis in an in vitro renal carcinoma model system.

Authors:  Toshihiko Okazaki; Daitoku Sakamuro
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-16       Impact factor: 4.553

7.  Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.

Authors:  Satya N Das; Pratima Khare; Manoj K Singh; Suresh C Sharma
Journal:  Indian J Med Res       Date:  2011-07       Impact factor: 2.375

8.  Activation of the JNK-c-Jun pathway in response to irradiation facilitates Fas ligand secretion in hepatoma cells and increases hepatocyte injury.

Authors:  Yinying Dong; Xiaoyun Shen; Mingyan He; Zhifeng Wu; Qiongdan Zheng; Yaohui Wang; Yuhan Chen; Sifan Wu; Jiefeng Cui; Zhaochong Zeng
Journal:  J Exp Clin Cancer Res       Date:  2016-07-18

9.  Adenovirus-mediated transfer of Fas ligand gene augments radiation-induced apoptosis in U-373MG glioma cells.

Authors:  N Shinoura; N Yamamoto; A Asai; T Kirino; H Hamada
Journal:  Jpn J Cancer Res       Date:  2000-10

10.  Emodin induces apoptosis of human cervical cancer hela cells via intrinsic mitochondrial and extrinsic death receptor pathway.

Authors:  Wang Yaoxian; Yu Hui; Zhang Yunyan; Liu Yanqin; Ge Xin; Wu Xiaoke
Journal:  Cancer Cell Int       Date:  2013-07-16       Impact factor: 5.722

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.